Please use this identifier to cite or link to this item:
|Title:||Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation|
|Citation:||Guo, C., Wang, C., Haider, H.Kh., Tan, R.-S., Shim, W.S.N., Wong, P., Sim, E.K.W. (2008). Myoblast Transplantation for Cardiac Repair: From Automyoblast to Allomyoblast Transplantation. Annals of Thoracic Surgery 86 (6) : 1841-1848. ScholarBank@NUS Repository. https://doi.org/10.1016/j.athoracsur.2008.08.038|
|Abstract:||Background: We sought to compare host immune cell kinetics, survival profile of donor skeletal myoblasts, and skeletal myoblast graft efficacy after autologous and allogeneic skeletal myoblast transplantation into a rat model of myocardial infarction. Methods: One week after myocardial infarction, 128 animals were divided into four groups: group 1 (n = 24, receiving medium only), group 2 (n = 24, receiving medium and cyclosporine), group 3 (n = 40, autologous skeletal myoblast transplantation), and group 4 (n = 40, allogeneic skeletal myoblast transplantation with cyclosporine treatment). Rats were euthanized 10 minutes, 1 day, and 4, 7, and 28 days later. Host immune cell kinetics were assessed by immunohistochemical studies for macrophages, and CD4+ and CD8+ lymphocytes. Donor skeletal myoblast survival was confirmed by tracking prelabeled signals, and quantified by β-gal assay. Heart function was evaluated by echocardiography. Results: A transient immune cell infiltration was demonstrated in group 3, with macrophage infiltration on day 1 and day 4, CD8+ cell infiltration on day 4 and day 7, and CD4+ cell infiltration on day 4. In group 4, immunocyte infiltration was slightly more severe than that in group 3. Automyoblasts and allomyoblasts showed no significant difference of survival from day 1 to day 7 (p > 0.10); however, on day 28, automyoblasts showed better survival than allomyoblasts (p < 0.05). Transplantation of allomyoblasts increased systolic heart function and limited heart dilation after myocardial injury to a similar degree as automyoblasts (p > 0.10). Conclusions: The use of allomyoblasts is feasible and effective for cardiac repair with immunosuppressive treatment as compared with automyoblasts. © 2008 The Society of Thoracic Surgeons.|
|Source Title:||Annals of Thoracic Surgery|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Feb 18, 2019
WEB OF SCIENCETM
checked on Feb 18, 2019
checked on Dec 16, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.